MwanzoEYPT • NASDAQ
add
EyePoint Inc
$ 14.92
Baada ya Saa za Kazi:(0.023%)-0.0035
$ 14.92
Imefungwa: 11 Mac, 20:00:00 GMT -4 · USD · NASDAQ · Kanusho
Bei iliyotangulia
$ 15.44
Bei za siku
$ 14.88 - $ 15.65
Bei za mwaka
$ 3.91 - $ 19.01
Thamani ya kampuni katika soko
1.25B USD
Wastani wa hisa zilizouzwa
1.70M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Habari za soko
Seeking Alpha
saa 8 zilizopita
The 10 most oversold S&P 500 stocks as markets digest the U.S.-Iran war
0.084%
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 620.00 | -94.65% |
Matumizi ya uendeshaji wa biashara | 12.39M | -8.95% |
Mapato halisi | -67.61M | -63.31% |
Kiwango cha faida halisi | elfu -10.90 | -2,952.31% |
Mapato kwa kila hisa | -0.81 | -26.56% |
EBITDA | -69.65M | -55.56% |
Asilimia ya kodi ya mapato | -0.28% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 306.09M | -17.48% |
Jumla ya mali | 364.00M | -13.02% |
Jumla ya dhima | 57.88M | -29.38% |
Jumla ya hisa | 306.11M | — |
hisa zilizosalia | 83.43M | — |
Uwiano wa bei na thamani | 4.17 | — |
Faida inayotokana na mali | -57.13% | — |
Faida inayotokana mtaji | -63.68% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -67.61M | -63.31% |
Pesa kutokana na shughuli | -65.05M | -81.45% |
Pesa kutokana na uwekezaji | -74.67M | 22.19% |
Pesa kutokana na ufadhili | 166.96M | 10.07% |
Mabadiliko halisi ya pesa taslimu | 27.24M | 37.08% |
Mtiririko huru wa pesa | -41.14M | -131.88% |
Kuhusu
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
Ilianzishwa
2000
Makao Makuu
Tovuti
Wafanyakazi
214
